EUROSCAN INTERNATIONAL NETWORK MEMBER AGENCIES: THEIR STRUCTURE, PROCESSES, AND OUTPUTS.
EUROSCAN INTERNATIONAL NETWORK MEMBER AGENCIES: THEIR STRUCTURE, PROCESSES, AND OUTPUTS.
复制标题
DOI：
10.1017/s0266462315000100
复制
发表时间：
2015-01
影响因子：
3.2
通讯作者：
de Almeida RT
中科院分区：
文献类型：
--
作者：
Packer C;Simpson S;de Almeida RT
目标：EuroScan国际网络是一个公共资助的卫生技术早期认识和警报（EAA）系统的全球网络。我们描述了欧洲扫描成员机构的系统和方法，并强调了增加合作的潜力。方法：EuroScan会员于2012年完成邮寄问卷，并辅以电话访谈，以获取额外信息并检查回答的等效性。信息更新于2013年3月至5月。结果：17个成员机构中有15个做出了回应。这些机构的主要目的是为保健服务的覆盖范围或报销决定以及进行二次研究的决定提供信息。信息的主要使用者是国家政府；卫生专业人员;卫生服务采购人员、专员和决策者；还有医疗服务提供者。大多数EuroScan机构规模都很小，几乎一半的机构全职员工少于两名。10个机构同时使用主动和被动识别方法，4个机构只使用主动识别方法。大多数在技术生命周期的实验或研究阶段开始识别。所有机构都在技术处于研究和确立之间，但处于推广阶段时对其进行评估。协作的障碍围绕着不同的系统目标、目的和需求；缺乏人手、资金或机会；语言差异;以及对传播的限制。结论：虽然确定了许多合作障碍，但大多数机构支持增加整个欧洲扫描网络或个别机构之间的合作。尽管在详细查明过程方面存在差异，但成员们认为这是发展更多合作的最可行阶段。
Objectives: The EuroScan International Network is a global network of publicly funded early awareness and alert (EAA) systems for health technologies. We describe the EuroScan member agency systems and methods, and highlight the potential for increased collaboration. Methods: EuroScan members completed postal questionnaires supplemented with telephone interviews in 2012 to elicit additional information and check equivalence of responses. Information was updated between March and May 2013. Results: Fifteen of the seventeen member agencies responded. The principal purpose of agencies is to inform decisions on coverage or reimbursement of health services and decisions on undertaking secondary research. The main users of information are national governments; health professionals; health services purchasers, commissioners, and decision makers; and healthcare providers. Most EuroScan agencies are small with almost half having fewer than two whole time equivalent staff. Ten agencies use both active and passive identification approaches, four use only active approaches. Most start identification in the experimental or investigational stages of the technology life cycle. All agencies assessed technologies when they are between the investigational and established, but under diffusion stages. Barriers to collaboration revolve around different system aims, purposes, and requirements; a lack of staff, finance, or opportunity; language differences; and restrictions on dissemination. Conclusions: Although many barriers to collaboration were identified, the majority of agencies were supportive of increased collaboration either involving the whole EuroScan Network or between individual agencies. Despite differences in the detailed identification processes, members thought that this was the most feasible phase to develop additional collaboration.